Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Lyotropic Delivery Systems Ltd. is currently overseeing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. This volume of activity indicates a focused prosecution phase for the company's delivery system innovations, where each matter is handled with high specificity.
These active matters are split between a matching number of distinct examiners and 2 distinct art units. This distribution suggests that each of the company's active matters is being treated as a separate technical inquiry within the broader Biotechnology & Pharmaceuticals sector, requiring a diverse set of legal arguments.
WELLES, COLMAN THOMAS is the busiest examiner for the portfolio, currently responsible for 1 pending office action. With only two distinct examiners involved in total, the company must tailor its legal arguments to the specific preferences of different officials to advance its filings. The outcome of the 1 pending office action under this examiner will serve as a significant indicator for the company's broader success in the field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WELLES, COLMAN THOMAS | 1 | 26.9% | +65.7% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.4% | +24.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18859589 | METHODS FOR THE TREATMENT OF ANXIETY DISORDER | WELLES, COLMAN THOMAS | — |
| 18564547 | METHODS FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND TRAUMATIC BRAIN INJURY WITH CANNABINOIDS | WHITE, DAWANNA SHAR-DAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18859589 | METHODS FOR THE TREATMENT OF ANXIETY DISORDER | WELLES, COLMAN THOMAS | — |
| 18564547 | METHODS FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND TRAUMATIC BRAIN INJURY WITH CANNABINOIDS | WHITE, DAWANNA SHAR-DAY | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18859589 | METHODS FOR THE TREATMENT OF ANXIETY DISORDER | WELLES, COLMAN THOMAS | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18564547 | METHODS FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND TRAUMATIC BRAIN INJURY WITH CANNABINOIDS | WHITE, DAWANNA SHAR-DAY | 1627 | §103§112 | Non-Final OA | — | Pending | Nov 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLyotropic Delivery Systems Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Colman Thomas Welles has the most, with 1 of Lyotropic Delivery Systems Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
